Leptin antagonism improves Rett syndrome phenotype in symptomatic Mecp2-deficient mice.
Saved in:
| Title: | Leptin antagonism improves Rett syndrome phenotype in symptomatic Mecp2-deficient mice. |
|---|---|
| Authors: | Belaïdouni Y; INMED, INSERM, Aix Marseille University, Marseille, France. Electronic address: yasmine.belaidouni@inserm.fr., Diabira D; INMED, INSERM, Aix Marseille University, Marseille, France., Salin P; IBDM, CNRS, Aix-Marseille University, Marseille, France., Brosset-Heckel M; INMED, INSERM, Aix Marseille University, Marseille, France., Valsamides V; INMED, INSERM, Aix Marseille University, Marseille, France., Graziano JC; INMED, INSERM, Aix Marseille University, Marseille, France., Santos C; Phenotype Expertise, Marseille, France., Menuet C; INMED, INSERM, Aix Marseille University, Marseille, France., Wayman GA; Program in Neuroscience, Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, WA, United States., Gaiarsa JL; INMED, INSERM, Aix Marseille University, Marseille, France. Electronic address: jean-luc.gaiarsa@inserm.fr. |
| Source: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2026 Apr; Vol. 23 (3), pp. e00910. Date of Electronic Publication: 2026 Apr 18. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
